CG-BM1 / Guangzhou Cellgenes Biotechnology - LARVOL DELTA

Efficacy and safety of Human Bone Marrow Derived Mesenchymal in Patients with pre-acute-on-chronic liver failure (ChiCTR) - P=N/A | N=66 | Not yet recruiting | Sponsor: The First Affiliated Hospital of Xi'an Jiaotong University; The First Affiliated Hospital of Xi'an Jiaotong University

New trial • Hepatology • Liver Failure